Tiriac, H., Plenker, D., Baker, L
Large meta-analyses and pooled data from randomized controlled trials demonstrate that GLP-1 receptor agonists do not increase the risk of depression, anxiety, suicidality, or other serious psychiatric adverse events compared to placebo
Strategic choiceslike a protein shake, Greek yogurt, or collagen peptidesallow patients to meet protein needs without feeling uncomfortably full
Furthermore, glutathione is expected to act on the type of melanin that is produced, commending the synthesis of pheomelanin (which has a pink to yellow hue) over eumelanin (which is brown to black), allowing lighter skin tones with satisfactory outcomes